Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials (2023)

First Author: Vale C

Attributed to: Method Meta-analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(23)00230-9

Publication URI: http://dx.doi.org/10.1016/s1470-2045(23)00230-9

Type: Journal Article/Review

Parent Publication: The Lancet Oncology

Issue: 7